Clinical Trial Update: A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients [Phase 4]

View source ↗

Summary

A pediatric open-label Phase 4 follow-up trial of Modigraf (tacrolimus) in de novo transplant recipients evaluating safety and efficacy; the study has been term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation
• Kidney Transplantation
• Liver Transplantation

Drugs mentioned

• Modigraf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Europe Ltd. | Conditions: Heart Transplantation, Kidney Transplantation | Phase 4 | Status: TERMINATED